Grace Therapeutics Inc (GRCE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GRCE | ABVC | CVM | ||
| Company | Grace Therapeutics Inc | Abvc Biopharma Inc | Cel-Sci Corp | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE Arca | ||
| Open | 3.48 | 2.20 | 6.35 | ||
| High | 3.48 | 2.28 | 6.70 | ||
| Low | 3.36 | 2.19 | 6.34 | ||
| Latest | 3.39 | 2.23 | 6.53 | ||
| Change | -0.08 | unch | -0.13 | ||
| % Change | -2.31% | unch | -1.95% | ||
| Volume | 42,600 | 80,600 | 59,682 | ||
| 20-Day Average Volume | 62,690 | 67,010 | 60,635 | ||
| Previous Close | 3.47 | 2.23 | 6.66 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 3.18 | 2.62 | 6.61 | ||
| 20-Day Raw Stochastic | 72.21% | 17.00% | 43.30% | ||
| 20-Day Relative Strength | 60.13 | 36.35 | 44.25 | ||
| Weighted Alpha | +4.38 | +112.13 | -61.79 | ||
| Today's Opinion | 96% Buy | 24% Sell | 56% Sell | ||
| Previous Opinion | 88% Buy | 24% Sell | 40% Sell | ||
| Last Month's Opinion | 24% Buy | Hold | Hold | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +7.45% since 12/03/25 | -13.23% since 12/03/25 | +9.56% since 12/03/25 | ||
| Low | 3.14 on 12/04/25 | 2.06 on 12/08/25 | 5.80 on 12/04/25 | ||
| High | 3.54 on 12/09/25 | 2.60 on 12/04/25 | 6.70 on 12/10/25 | ||
| 1-Month | |||||
| %Chg | +13.38% since 11/10/25 | -21.75% since 11/10/25 | -9.18% since 11/10/25 | ||
| Low | 2.98 on 11/11/25 | 2.06 on 12/08/25 | 5.56 on 12/03/25 | ||
| High | 3.54 on 12/09/25 | 3.06 on 11/17/25 | 7.80 on 11/28/25 | ||
| 3-Month | |||||
| %Chg | +3.99% since 09/10/25 | -16.79% since 09/10/25 | -32.54% since 09/10/25 | ||
| Low | 2.91 on 09/30/25 | 2.06 on 12/08/25 | 5.56 on 12/03/25 | ||
| High | 3.54 on 12/09/25 | 3.40 on 10/07/25 | 10.83 on 10/03/25 | ||
| 6-Month | |||||
| %Chg | +13.76% since 06/10/25 | +34.34% since 06/10/25 | +169.83% since 06/10/25 | ||
| Low | 2.80 on 08/04/25 | 1.58 on 06/12/25 | 2.06 on 06/18/25 | ||
| High | 3.74 on 07/14/25 | 5.48 on 07/08/25 | 13.48 on 08/27/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 53,695 | 54,191 | 53,386 | ||
| Shares Outstanding, K | 15,474 | 24,301 | 8,016 | ||
| Annual Sales | 0 | 510,000 | 0 | ||
| Annual Net Income | -9,570,000 | -4,900,000 | -26,920,000 | ||
| Last Quarter Sales | 0 | 800,000 | 0 | ||
| Last Quarter Net Income | -940,000 | -1,250,000 | -5,660,000 | ||
| 60-Month Beta | 0.59 | 0.24 | 0.49 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.15 on 11/13/25 | -0.05 on 10/31/25 | -1.36 on 08/14/25 | ||
| Latest Earnings Date | 02/12/26 | 04/21/26 | 01/12/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||